Genetic screening of the LPL gene in hypertriglyceridaemic patients

Atherosclerosis

Volumn 199, Issue 1, 2008, Pages 187-192

  Wright, William T ^a   Young, Ian S ^a   Nicholls, D Paul ^a   Graham, Colin A ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

HTG; Hypertriglyceridaemia; LPL; MLPA; N291S; p.N318S; Sequence

Indexed keywords

LIPOPROTEIN LIPASE;

ADULT; ARTICLE; FEMALE; GENE DELETION; GENE DUPLICATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; CHOLESTEROL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; NORTHERN IRELAND; POLYMORPHISM, GENETIC; RISK FACTORS; TRIGLYCERIDES;

EID: 45449094240     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.10.029     Document Type: Article

References (24)

1. Assmann G., Schulte H., and von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 77 (1996) 1179-1184
2. Ginsberg H.N. Hypertriglyceridemia: new insights and new approaches to pharmacologic therapy. Am J Cardiol 87 (2001) 1174-1180
3. Wong H., and Schotz M.C. The lipase gene family. J Lipid Res 43 (2002) 993-999
4. Busch C.P., and Hegele R.A. Variation of candidate genes in triglyceride metabolism. J Cardiovasc Risk 7 (2000) 309-315
5. McDonnell M.G., Young I.S., Nicholls D.P., Archbold G.P., and Graham C.A. Genetics of the lipoprotein lipase gene and hypertriglyceridaemia. Br J Biomed Sci 60 (2003) 84-88
6. Hu Y., Liu W., Huang R., and Zhang X. A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases. J Lipid Res 47 (2006) 1908-1914
7. Jeanpierre M. A rapid method for purification of DNA from blood. Nucleic Acid Res 15 (1987) 9611
8. den Dunnen J.T., and Paalman M.H. Standardizing mutation nomenclature: why bother?. Hum Mutat 22 (2003) 181-182
9. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1 (1990) 43-46
10. Perneger T.V. What's wrong with Bonferroni adjustments. Br Med J 316 (1998) 1236-1238
11. Perneger T.V. Adjusting for multiple testing in studies is less important than other concerns. Br Med J 318 (1999) 1288
12. Pennacchio L.A., Olivier M., Hubacek J.A., Krauss R.M., Rubin E.M., and Cohen J.C. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11 (2002) 3031-3038
13. Talmud P.J., Hawe E., Martin S., et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11 (2002) 3039-3046
14. Tosi I., Toledo-Leiva P., Neuwirth C., Naoumova R.P., and Soutar A.K. Genetic defects causing familial hypercholesterolaemia: identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic. Atherosclerosis 194 (2007) 102-111
15. Johnson G.C., Esposito L., Barratt B.J., et al. Haplotype tagging for the identification of common disease genes. Nat Genet 29 (2001) 233-237
16. Stengard J.H., Clark A.G., Weiss K.M., et al. Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism. Am J Hum Genet 71 (2002) 501-517
17. Tiret L., Poirier O., Nicaud V., et al. Heterogeneity of linkage disequilibrium in human genes has implications for association studies of common diseases. Hum Mol Genet 11 (2002) 419-429
18. Nickerson D.A., Taylor S.L., Weiss K.M., et al. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat Genet 19 (1998) 233-240
19. Pimstone S.N., Clee S.M., Gagne S.E., et al. A frequently occuring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. J Lipid Res 37 (1996) 1675-1684
20. Merkel M., Eckel R.H., and Goldberg I.J. Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 43 (2002) 1997-2006
21. Kastelein J.J., Groenemeyer B.E., Hallman D.M., et al. The ASN9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. Clin Genet 53 (1998) 27-33
22. Razzaghi H., Aston C.E., Hamman R.F., and Kamboh M.I. Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels. Hum Genet 107 (2000) 257-267
23. Zhang H., Reymer P.W.A., Liu M.S., et al. Patients with ApoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291 → Ser mutation in the human LPL gene. Arterioscler Thromb Vasc Biol 15 (1995) 1695-1703
24. Razzaghi H., Day B.W., McClure R.J., and Kamboh M.I. Structure-function analysis of D9N and N291S mutations in human lipoprotein lipase using molecular modeling. J Mol Graph Model 19 (2001) 487-494